Mutation of GNAQ is strongly associated with the non-T cell-inflamed phenotype across tumors and predominately in uveal melanoma, a subset of melanoma known to be resistant to immune-checkpoint blockade [44] (FDR-adjusted P = 0.050). This evidence concerns the gene GNAQ and uveal melanoma.